| Literature DB >> 27469182 |
Meghana Nitin Sathe1, Alvin Jay Freeman2.
Abstract
Pulmonary disease is the primary cause of morbidity and mortality in people with cystic fibrosis (CF), but significant involvement within gastrointestinal, pancreatic, and hepatobiliary systems occurs as well. As in the airways, defects in CFTR alter epithelial surface fluid, mucus viscosity, and pH, increasing risk of stasis through the various hollow epithelial-lined structures of the gastrointestinal tract. This exerts secondary influences that are responsible for most gastrointestinal, pancreatic, and hepatobiliary manifestations of CF. Understanding these gastrointestinal morbidities of CF is essential in understanding and treating CF as a multisystem disease process and improving overall patient care.Entities:
Keywords: CF and GI manifestations; CF pancreas; CFLD (CF liver disease); PERT (pancreatic enzyme replacement therapy)
Mesh:
Substances:
Year: 2016 PMID: 27469182 DOI: 10.1016/j.pcl.2016.04.008
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278